Multi-omic spatial profiling reveals the unique virus-driven immune landscape of COVID-19 placentitis
Summary COVID-19 placentitis, a rare complication of maternal SARS-CoV-2 infection, only shows detectable virus in the placenta of a subset of cases. We provide a deep multi-omic spatial characterisation of placentitis from obstetrically complicated maternal COVID-19 infection. We found that SARS-CoV-2 infected placentas have a distinct transcriptional and immunopathological signature. This signature overlaps with virus-negative cases supporting a common viral aetiology. An inverse correlation between viral load and disease duration suggests viral clearance over time. Quantitative spatial analyses revealed a unique microenvironment surrounding virus-infected trophoblasts characterised by PDL1-expressing macrophages, T-cell exclusion, and interferon blunting. In contrast to uninfected mothers, ACE2 was localised to the maternal side of the placental trophoblast layer of almost all mothers with placental SARS-CoV-2 infection, which may explain variable susceptibility to placental infection. Our results demonstrate a pivotal role for direct placental SARS-CoV-2 infection in driving the unique immunopathology of COVID-19 placentitis.Graphical Abstract <jats:fig id="ufig1" position="anchor" orientation="portrait" fig-type="figure"><jats:graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="516398v1_ufig1" position="float" orientation="portrait" /></jats:fig>.
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
bioRxiv.org - (2023) vom: 12. März Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pugh, Matthew [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
---|
doi: |
10.1101/2022.11.14.516398 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XBI037879979 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XBI037879979 | ||
003 | DE-627 | ||
005 | 20231205145845.0 | ||
007 | cr uuu---uuuuu | ||
008 | 221116s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2022.11.14.516398 |2 doi | |
035 | |a (DE-627)XBI037879979 | ||
035 | |a (biorXiv)10.1101/2022.11.14.516398 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pugh, Matthew |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multi-omic spatial profiling reveals the unique virus-driven immune landscape of COVID-19 placentitis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Summary COVID-19 placentitis, a rare complication of maternal SARS-CoV-2 infection, only shows detectable virus in the placenta of a subset of cases. We provide a deep multi-omic spatial characterisation of placentitis from obstetrically complicated maternal COVID-19 infection. We found that SARS-CoV-2 infected placentas have a distinct transcriptional and immunopathological signature. This signature overlaps with virus-negative cases supporting a common viral aetiology. An inverse correlation between viral load and disease duration suggests viral clearance over time. Quantitative spatial analyses revealed a unique microenvironment surrounding virus-infected trophoblasts characterised by PDL1-expressing macrophages, T-cell exclusion, and interferon blunting. In contrast to uninfected mothers, ACE2 was localised to the maternal side of the placental trophoblast layer of almost all mothers with placental SARS-CoV-2 infection, which may explain variable susceptibility to placental infection. Our results demonstrate a pivotal role for direct placental SARS-CoV-2 infection in driving the unique immunopathology of COVID-19 placentitis.Graphical Abstract <jats:fig id="ufig1" position="anchor" orientation="portrait" fig-type="figure"><jats:graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="516398v1_ufig1" position="float" orientation="portrait" /></jats:fig> | ||
650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
700 | 1 | |a Fennell, Éanna |4 aut | |
700 | 1 | |a Leahy, Ciara I |4 aut | |
700 | 1 | |a Perry, Tracey |4 aut | |
700 | 1 | |a Hargitai, Beata |4 aut | |
700 | 1 | |a Marton, Tamas |4 aut | |
700 | 1 | |a Hunter, Kelly J. |4 aut | |
700 | 1 | |a Halford, Graham |4 aut | |
700 | 1 | |a Yilmaz, Hale Onder |4 aut | |
700 | 1 | |a Stamataki, Zania |0 (orcid)0000-0003-3823-4497 |4 aut | |
700 | 1 | |a Reynolds, Gary |4 aut | |
700 | 1 | |a Hill, Harriet J. |4 aut | |
700 | 1 | |a Willcox, Benjamin E. |4 aut | |
700 | 1 | |a Steven, Neil |4 aut | |
700 | 1 | |a Thornton, Catherine A. |4 aut | |
700 | 1 | |a Dojcinov, Stefan D. |4 aut | |
700 | 1 | |a Culhane, Aedin |4 aut | |
700 | 1 | |a Murray, Paul G. |4 aut | |
700 | 1 | |a Taylor, Graham S. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 12. März |
773 | 1 | 8 | |g year:2023 |g day:12 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2022.11.14.516398 |z kostenfrei |3 Volltext |
912 | |a GBV_XBI | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2023 |b 12 |c 03 |